Mozambique vs Peru: Access to anti-retroviral drugs, female
Mozambique
85.0%
in 2024
Peru
86.0%
in 2024
Mozambique rank
49th
Peru rank
47th
Access to anti-retroviral drugs, female over time
- Mozambique
- Peru
How they compare
Peru currently reports 86.0% against 85.0% in Mozambique, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Peru ahead.
Mozambique ranks 49th and Peru ranks 47th of 141 countries.
Peru has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mozambique | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 12.3% | 8.9% | Peru |
| 2010s | 41.4% | 59.6% | 18.2% | Peru |
| 2020s | 76.6% | 78.0% | 1.4% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Mozambique or Peru?
- Peru, at 86.0% against 85.0% in Mozambique as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Mozambique and Peru?
- 1.0%, with Peru ahead.
- How many years of comparable data are there for Mozambique and Peru?
- 25 years are reported by both, from 2000 to 2024.
- How do Mozambique and Peru rank globally for access to anti-retroviral drugs, female?
- Mozambique ranks 49th and Peru ranks 47th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.